ReviewFrontiers in medicine2026
Federated learning for privacy-preserving ophthalmic artificial intelligence: clinical applications and translational challenges.
Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Federated learning (FL) is increasingly relevant to ophthalmology because retinal photographs, optical coherence tomography (OCT), OCT angiography, visual fields, and linked clinical records are clinically valuable but difficult to pool across institutions. In this narrative review, we synthesize ophthalmology-focused FL literature across diabetic retinopathy (DR), glaucoma, age-related macular degeneration (AMD), pediatric retinal disease, multi-disease retinal diagnostics, and emerging ophthalmic platforms. Current evidence suggests that FL can support collaborative AI development without centralizing raw patient data, and selected studies show performance close to centralized training under controlled retrospective or multicenter experimental conditions. For example, multicenter glaucoma detection from volumetric OCT achieved an AUC of 0.92 with FL compared with 0.94 for centralized training. However, FL is privacy-enhancing rather than privacy-complete, and most ophthalmic FL systems have not yet undergone prospective clinical validation. Model updates may remain vulnerable to gradient inversion, membership inference, poisoning, site-level bias, and latent identity or attribute leakage. For eye-care networks, the main value of FL is therefore not simply algorithmic performance but a governance model for privacy-conscious collaboration. Prospective validation, interoperability, explainability, workflow integration, privacy auditing, and clear responsibility for monitoring are needed before FL-enabled ophthalmic AI can be deployed routinely.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.